Episode Details
Back to Episodes
mRNA Flu Vaccine Gets FDA Green Light | St. Louis News
Description
Washington University’s breakthrough mRNA flu vaccine, now FDA-approved, could revolutionize flu prevention by offering lasting protection for up to nine months—far outpacing traditional vaccines that struggle with the flu’s rapid mutations. Early results show it outperforms other experimental approaches, including a universal flu candidate, delivering stronger, longer-lasting immunity. While not yet a universal vaccine, this innovation promises faster adaptation to new strains and could dramatically reduce flu outbreaks.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/23ea20927c3ef26c